GLP-1 drugs , or glucagon-like peptide-1 receptor agonists , represent a truly innovation in how we approach diabetes mellitus . These new medications function to imitating the body’s own GLP-1 https://ianbgid634904.vblogetin.com/48069464/glp-1-a-major-advance-in-blood-sugar-treatment